Literature DB >> 23375939

Reasons for uncontrolled seizures in adults; the impact of pseudointractability.

Ali A Asadi-Pooya1, Mehrdad Emami, Nahid Ashjazadeh, Alireza Nikseresht, Abdolhamid Shariat, Peyman Petramfar, Gholamali Yousefipour, Afshin Borhani-Haghighi, Sadegh Izadi, Abbas Rahimi-Jaberi.   

Abstract

PURPOSE: We investigated the various possible reasons for uncontrolled seizures in patients 18 years of age and older to determine the impact of pseudointractability. We also tried to investigate the various forms of pseudointractability.
METHODS: In this cross-sectional study, all patients 18 years of age and older with their first seizure occurring at least six months prior to the referral date, taking at least one antiepileptic drug (AED) and having at least one seizure in the past three months were studied. The presumed reason for uncontrolled seizures was arbitrarily considered to be one of these five categories: Poor compliance; Wrong medication (misclassification); Wrong dose of the correct medication; Diagnosis other than epilepsy; and finally, Medically-refractory epilepsy. Statistical analyses were performed using Chi-square and Fisher's exact tests, and a P value less than 0.05 was considered significant.
RESULTS: 350 patients were referred to us due to uncontrolled seizures. One hundred ninety-one (55%) were male and 159 (45%) were female. Twelve percent of the patients had diagnoses other than epilepsy, 40% had indeed medically-refractory epilepsy; 29% were taking the wrong AEDs (misclassified epilepsy); 18% were taking suboptimal doses of AEDs; and 1% had poor drug compliance. The most common reason for uncontrolled seizures among patients with idiopathic generalized epilepsy was taking the wrong AED. However, among patients with focal epilepsy, true medically-refractory epilepsy was the most common reason.
CONCLUSION: Uncontrolled seizures are a commonly encountered problem, especially at epilepsy clinics and one should consider all possible reasons for these uncontrolled seizures. The mainstay for making a correct diagnosis is a detailed clinical history.
Copyright © 2013 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23375939     DOI: 10.1016/j.seizure.2013.01.010

Source DB:  PubMed          Journal:  Seizure        ISSN: 1059-1311            Impact factor:   3.184


  8 in total

Review 1.  Psychogenic nonepileptic seizures: a concise review.

Authors:  Ali A Asadi-Pooya
Journal:  Neurol Sci       Date:  2017-03-08       Impact factor: 3.307

Review 2.  Lennox-Gastaut syndrome: a comprehensive review.

Authors:  Ali A Asadi-Pooya
Journal:  Neurol Sci       Date:  2017-11-09       Impact factor: 3.307

3.  Seizure outcome in patients with juvenile absence epilepsy.

Authors:  Ali A Asadi-Pooya; Mohsen Farazdaghi
Journal:  Neurol Sci       Date:  2015-11-03       Impact factor: 3.307

4.  SCN1A and SCN1B gene polymorphisms and their association with plasma concentrations of carbamazepine and carbamazepine 10, 11 epoxide in Iranian epileptic patients.

Authors:  Soha Namazi; Negar Azarpira; Katayoon Javidnia; Mehrdad Emami; Rahimeh Rahjoo; Razieh Berahmand; Afshin Borhani-Haghighi
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

5.  Medication Adherence in Indian Epilepsy Patients.

Authors:  Shrawan Kumar; Mamta Bhushan Singh; Amit Kumar; M V Padma Srivastava; Vinay Goyal
Journal:  Ann Indian Acad Neurol       Date:  2021-06-17       Impact factor: 1.383

6.  Automated seizure detection with noninvasive wearable devices: A systematic review and meta-analysis.

Authors:  Vaidehi Naganur; Shobi Sivathamboo; Zhibin Chen; Shitanshu Kusmakar; Ana Antonic-Baker; Terence J O'Brien; Patrick Kwan
Journal:  Epilepsia       Date:  2022-05-28       Impact factor: 6.740

Review 7.  Underutilization of epilepsy surgery: Part I: A scoping review of barriers.

Authors:  Debopam Samanta; Adam P Ostendorf; Erin Willis; Rani Singh; Satyanarayana Gedela; Ravindra Arya; M Scott Perry
Journal:  Epilepsy Behav       Date:  2021-02-18       Impact factor: 2.937

8.  Impacts of the COVID-19 pandemic on Iranian patients with epilepsy.

Authors:  Ali A Asadi-Pooya; Mohsen Farazdaghi; Mehdi Bazrafshan
Journal:  Acta Neurol Scand       Date:  2020-07-22       Impact factor: 3.915

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.